Abstract:Background and Aims: Recent studies have shown epsterin-Barr virus (EBV) infection is related to the development of gastric cancer. In particular, latent EBV infection usually established persistently and promoted tumor progression. The zinc finger E-box binding factor 1 (ZEB1) mediated transcriptional silencing of intermediate-early genes and induced EBV infection from lytic to latent stage. We aim to study the effect of ZEB1 on modulating latent-lytic switch in gastric cancer, and to explore the potential of ZEB1 as a novel molecular target for the intervention of EBV associated Gastric Cancer (EBVaGc). Method Gastric cancer cell-lines with latent (YCC10 cell-line) and lytic (AGS-EBV infected cell-line) EBV infection were used in this study. Loss or gain function of ZEB1 was obtained by ZEB1 siRNA knockdown or forced re-expression experiments, respectively. The modulation of the intermediateearly gene and apoptotic mediators were assessed by real time RT-PCR and Western blot. Cell growth was evaluated by cell viability assay and colony formation assay, and cell cycle by flow cytometry analysis. Results: siRNA-mediated knockdown of ZEB1 in latent EBV infected cell-line YCC10 triggered a 3-fold enhanced expression of BZLF1, an intermediateearly gene of EBV, but a 5-fold reduction in expression of EBV nuclear antigen 1 (EBNA1), a gene that plays essential roles in enabling the replication and persistence of EBV genomes in latently infected cells and activating EBV latent gene expression. By doing so, knockdown of ZEB1 in YCC10 significantly inhibited cell viability (100% to 84%, P<0.01), suppressed cell proliferation as evidenced by reduced S phase cells (P=0.005), caused cell cycle arrest in G2M phase (P=0.006) and induced cell apoptosis (4.6±0.15% to 7.1±1.36%, P<0.05), The induction of cell apoptosis is confirmed by the cleavage of caspase-3 and PARP. On the other hand, over-expression of ZEB1 in lytic EBV infected cell line AGS-EBV through transient transfection significantly increased cell viability (P<0.01), induced S phase cell number (32.9±1.17% to 40.3±23.89%, P<0.05) and promoted colony formation (P<0.01). Conclusion: ZEB1 is involved in the latent-lytic switch of EBV associated gastric cancer. Inhibition of ZEB1 may be a promising approach for the treatment of EBVaGc.

The Chemopreventive Compound Curcumin is an Efficient Inhibitor of Epstein‐Barr Virus BZLF1 Transcription in Raji DR‐LUC Cells*

Identification of Curcumin As a Novel Natural Inhibitor of Rdna Transcription.

Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.

M1912 Role of Zinc Finger E-Box Binding Factor 1 Modulating Latent-Lytic Switch of Epstein-Barr Virus in Gastric Cancer

Curcumin derivative C210 induces Epstein–Barr virus lytic cycle and inhibits virion production by disrupting Hsp90 function

Expression Analysis Of Cdc42 In Lung Cancer And Modulation Of Its Expression By Curcumin In Lung Cancer Cell Lines

Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells.

Curcumin induces apoptosis and inhibits growth of human Burkitt’s lymphoma in xenograft mouse model

Curcumin Mitigates the Epithelial‐to‐mesenchymal Transition in Biliary Epithelial Cells Through Upregulating CD109 Expression

Transactivators Zta and Rta of Epstein-Barr Virus Promote G0/G1 to S Transition in Raji Cells: a Novel Relationship Between Lytic Virus and Cell Cycle.

Curcumin, a Potent Anti-Tumor Reagent, is a Novel Histone Deacetylase Inhibitor Regulating B-NHL Cell Line Raji Proliferation

Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells.

(-)-Epigallocatechin-3-gallate Inhibition of Epstein-Barr Virus Spontaneous Lytic Infection Involves Downregulation of Latent Membrane Protein 1

Combination of Betulinic Acid and Chidamide Synergistically Inhibits Epstein-Barr Virus Replication Through Over-Generation of Reactive Oxygen Species

Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on Several Parameters of Epstein-Barr Virus Infection.

Anticancer Effect of Curcumin on Human B Cell Non-Hodgkin's Lymphoma

Effects of Cucurbitacin B on the Activation, Proliferation and Apoptosis of Mouse Lymphocytes

The inhibitory effect of rBCG on EB virus-positive tumours using an EB virus fusion gene

Curcumin Exerts Anti-Tumor Effects on Diffuse Large B Cell Lymphoma Via Regulating PPARγ Expression.

[Activity of Curcumin Against Human Cytomegalovirus Infection in Vitro].

Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir